| Variables . | Total . | Blood Donors . | Clinics . | P . |
|---|---|---|---|---|
| N (%) | 247 | 109 (44) | 138 (56) | n.s. |
| Female gender (%) | 153 (62) | 69 (63) | 84 (61) | n.s. |
| Median age (years) | 43.4 | 42.6 | 44 | n.s. |
| Country of Origin (%) | ||||
| • Spain | 29 (12) | 9 | 20 | .09 |
| • Latin America | 179 (72.5) | 88 | 91 | n.s. |
| • Africa | 21 (8.5) | 1 | 20 | <.01 |
| • Others | 18 (7.3) | 11 | 7 | n.s. |
| HTLV symptomatic disease (%) | 57 (23) | 0 | 57 (41) | <.01 |
| HIV coinfection | 4 (1.6) | 0 | 4 (3) | <.01 |
| Variables . | Total . | Blood Donors . | Clinics . | P . |
|---|---|---|---|---|
| N (%) | 247 | 109 (44) | 138 (56) | n.s. |
| Female gender (%) | 153 (62) | 69 (63) | 84 (61) | n.s. |
| Median age (years) | 43.4 | 42.6 | 44 | n.s. |
| Country of Origin (%) | ||||
| • Spain | 29 (12) | 9 | 20 | .09 |
| • Latin America | 179 (72.5) | 88 | 91 | n.s. |
| • Africa | 21 (8.5) | 1 | 20 | <.01 |
| • Others | 18 (7.3) | 11 | 7 | n.s. |
| HTLV symptomatic disease (%) | 57 (23) | 0 | 57 (41) | <.01 |
| HIV coinfection | 4 (1.6) | 0 | 4 (3) | <.01 |
Abbreviations: HIV, human immunodeficiency virus; HTLV, human T-cell leukemia virus type 1; n.s., nonsignificant.
| Variables . | Total . | Blood Donors . | Clinics . | P . |
|---|---|---|---|---|
| N (%) | 247 | 109 (44) | 138 (56) | n.s. |
| Female gender (%) | 153 (62) | 69 (63) | 84 (61) | n.s. |
| Median age (years) | 43.4 | 42.6 | 44 | n.s. |
| Country of Origin (%) | ||||
| • Spain | 29 (12) | 9 | 20 | .09 |
| • Latin America | 179 (72.5) | 88 | 91 | n.s. |
| • Africa | 21 (8.5) | 1 | 20 | <.01 |
| • Others | 18 (7.3) | 11 | 7 | n.s. |
| HTLV symptomatic disease (%) | 57 (23) | 0 | 57 (41) | <.01 |
| HIV coinfection | 4 (1.6) | 0 | 4 (3) | <.01 |
| Variables . | Total . | Blood Donors . | Clinics . | P . |
|---|---|---|---|---|
| N (%) | 247 | 109 (44) | 138 (56) | n.s. |
| Female gender (%) | 153 (62) | 69 (63) | 84 (61) | n.s. |
| Median age (years) | 43.4 | 42.6 | 44 | n.s. |
| Country of Origin (%) | ||||
| • Spain | 29 (12) | 9 | 20 | .09 |
| • Latin America | 179 (72.5) | 88 | 91 | n.s. |
| • Africa | 21 (8.5) | 1 | 20 | <.01 |
| • Others | 18 (7.3) | 11 | 7 | n.s. |
| HTLV symptomatic disease (%) | 57 (23) | 0 | 57 (41) | <.01 |
| HIV coinfection | 4 (1.6) | 0 | 4 (3) | <.01 |
Abbreviations: HIV, human immunodeficiency virus; HTLV, human T-cell leukemia virus type 1; n.s., nonsignificant.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
